MJA Insight, 14 October 2013
Author: Paul Komesaroff
“THE practice of pharmaceutical companies paying physicians to deliver information about their products was questioned in a recent article published in Open Medicine.
Apparently, this occurs commonly in the US, where it often involves a contractual agreement by the doctors to adhere to company materials…
Although there are no data about the existence of a similar system in Australia it is clear that at least informal arrangements exist…”
Find article here.